Molybdenum cofactor deficiency type B knock-in mouse models carrying patient-identical mutations and their rescue by singular AAV injections

Human Genetics
Jochen Reiss

Abstract

Molybdenum cofactor deficiency is an autosomal, recessively inherited metabolic disorder, which, in the absence of an effective therapy, leads to early childhood death due to neurological deterioration. In type A of the disease, cyclic pyranopterin monophosphate (cPMP) is missing, the first intermediate in the biosynthesis of the cofactor, and a biochemical substitution therapy using cPMP has been developed. A comparable approach for type B of the disease with a defect in the second step of the synthesis, formation of molybdopterin, so far has been hampered by the extreme instability of the corresponding metabolites. To explore avenues for a successful and safe gene therapy, knock-in mouse models were created carrying the mutations c.88C>T (p.Q30X) and c.726_727delAA, which are also found in human patients. Recombinant adeno-associated viruses (rAAVs) were constructed and used for postnatal intrahepatic injections of MoCo-deficient mice in a proof-of-concept approach. Singular administration of an appropriate virus dose in 60 animals prevented the otherwise devastating phenotype to a variable extent. While untreated mice did not survive for more than 2 weeks, some of the treated mice grew up to adulthood in both sexes.

References

Jun 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J L JohnsonS K Wadman
Dec 10, 2002·Human Molecular Genetics·Heon-Jin LeeJochen Reiss
May 20, 2003·Human Mutation·Jochen Reiss, Jean L Johnson
Apr 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Andreas MatthiesSilke Leimkühler
Apr 30, 2004·Human Molecular Genetics·Günter SchwarzJochen Reiss
Jun 2, 2006·Molecular Genetics and Metabolism·Rita HahnewaldJochen Reiss
Aug 14, 2009·Nature·Günter SchwarzMarkus W Ribbe
Apr 14, 2010·Pediatrics·Alex VeldmanGuenter Schwarz
Oct 30, 2010·Human Mutation·Jochen Reiss, Rita Hahnewald
Nov 2, 2011·Clinical Genetics·J ReissM Holder-Espinasse
Sep 19, 2012·Pediatrics·Marrit M HitzertFrancjan J van Spronsen
Mar 13, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Konstantin MechlerMarkus Ries
Dec 15, 2015·Molecular Genetics and Metabolism·Paldeep S Atwal, Fernando Scaglia
Mar 3, 2017·Current Protocols in Mouse Biology·Micheal A McLellanAlexander R Pinto
May 26, 2017·American Journal of Medical Genetics. Part a·Jan G M HuijmansGrazia M S Mancini
Jul 3, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Michael F NasoWilliam R Strohl
Sep 14, 2017·Journal of Inherited Metabolic Disease·Katrin HinderhoferMarkus Ries

❮ Previous
Next ❯

Citations

Oct 17, 2020·Current Opinion in Clinical Nutrition and Metabolic Care·Viktor Kožich, Tomas Majtan
Aug 14, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Julie M ZiobroRenée A Shellhaas

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
Jose Angel Santamaria-AraujoGuenter Schwarz
Cellular and Molecular Life Sciences : CMLS
Günter Schwarz
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Charlotte M A LuboutFrancjan J Van Spronsen
© 2022 Meta ULC. All rights reserved